Ensuring Leading Position For GSK Consumer Products Touted In Management Shift
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and generally weaker markets.
You may also be interested in...
Glaxo Launches Flonase OTC, Banks On More Consumer Growth Drivers
CEO Andrew Witty says the consumer business GSK is forming through brand divestitures and its JV with Novartis is a part of “the company I've been trying to create for seven years.” GSK’s OTC Flonase reached U.S. stores Feb. 3, a sign of additional product launches he expects the consumer health JV to do.
Glaxo Launches Flonase OTC, Banks On More Consumer Growth Drivers
CEO Andrew Witty says the consumer business GSK is forming through brand divestitures and its JV with Novartis is a part of “the company I've been trying to create for seven years.” GSK’s OTC Flonase reached U.S. stores Feb. 3, a sign of additional product launches he expects the consumer health JV to do.
B&L ReNu recall
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: